{"id":"https://openalex.org/W2073715063","doi":"https://doi.org/10.1196/annals.1333.091","title":"Inhibitors of Advanced Glycation End Product Formation and Neurovascular Dysfunction in Experimental Diabetes","display_name":"Inhibitors of Advanced Glycation End Product Formation and Neurovascular Dysfunction in Experimental Diabetes","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2073715063","doi":"https://doi.org/10.1196/annals.1333.091","mag":"2073715063","pmid":"https://pubmed.ncbi.nlm.nih.gov/16037306"},"language":"en","primary_location":{"id":"doi:10.1196/annals.1333.091","doi":"https://doi.org/10.1196/annals.1333.091","is_oa":false,"landing_page_url":"https://doi.org/10.1196/annals.1333.091","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073715063"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064776633","display_name":"Norman E. Cameron","orcid":"https://orcid.org/0000-0003-3169-6277","observed_orcids":["https://orcid.org/0000-0003-3169-6277"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"NORMAN E. CAMERON","raw_affiliation_strings":["School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK. n.e.cameron@abdn.ac.uk","School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK. n.e.cameron@abdn.ac.uk","institution_ids":["https://openalex.org/I195460627"]},{"raw_affiliation_string":"School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042062050","display_name":"Thomas M. Gibson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T MICHAEL GIBSON","raw_affiliation_strings":["School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005302156","display_name":"Matthew R. Nangle","orcid":"https://orcid.org/0000-0002-7704-4840","observed_orcids":["https://orcid.org/0000-0002-7704-4840"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MATTHEW R. NANGLE","raw_affiliation_strings":["School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071633791","display_name":"M. A. Cotter","orcid":"https://orcid.org/0000-0003-4930-4390","observed_orcids":["https://orcid.org/0000-0003-4930-4390"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MARY A. COTTER","raw_affiliation_strings":["School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK","institution_ids":["https://openalex.org/I195460627"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5064776633"],"corresponding_institution_ids":["https://openalex.org/I195460627"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.6818,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.57692308,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"1043","issue":"1","first_page":"784","last_page":"792"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-glycation-end-products","display_name":"advanced glycation end products","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-lipoxidation-end-products","display_name":"advanced lipoxidation end products","score":0.9169999957084656},{"id":"https://openalex.org/keywords/diabetic-neuropathy","display_name":"diabetic neuropathy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/aminoguanidine","display_name":"aminoguanidine","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pyridoxamine","display_name":"pyridoxamine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/benfotiamine","display_name":"benfotiamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.7699999809265137},{"id":"https://openalex.org/keywords/nerve-blood-flow","display_name":"nerve blood flow","score":0.7760000228881836},{"id":"https://openalex.org/keywords/nerve-conduction-velocity","display_name":"nerve conduction velocity","score":0.8479999899864197},{"id":"https://openalex.org/keywords/thermal-hyperalgesia","display_name":"thermal hyperalgesia","score":0.7630000114440918},{"id":"https://openalex.org/keywords/mechanical-allodynia","display_name":"mechanical allodynia","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pentose-phosphate-pathway","display_name":"pentose phosphate pathway","score":0.8240000009536743},{"id":"https://openalex.org/keywords/neurovascular-dysfunction","display_name":"neurovascular dysfunction","score":0.6890000104904175},{"id":"https://openalex.org/keywords/diabetic-microvascular-complications","display_name":"diabetic microvascular complications","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2779178840","wikidata":"https://www.wikidata.org/wiki/Q2046550","display_name":"Diabetic neuropathy","level":3,"score":0.6775052547454834},{"id":"https://openalex.org/C147990577","wikidata":"https://www.wikidata.org/wiki/Q25790","display_name":"Glycation","level":3,"score":0.6755694150924683},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6499245762825012},{"id":"https://openalex.org/C2776997535","wikidata":"https://www.wikidata.org/wiki/Q2556837","display_name":"Advanced glycation end-product","level":4,"score":0.6391569375991821},{"id":"https://openalex.org/C2778428028","wikidata":"https://www.wikidata.org/wiki/Q2541149","display_name":"Pyridoxamine","level":4,"score":0.5843404531478882},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5539066195487976},{"id":"https://openalex.org/C179253579","wikidata":"https://www.wikidata.org/wiki/Q6276958","display_name":"Nerve conduction velocity","level":2,"score":0.5024528503417969},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.47979193925857544},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.436428040266037},{"id":"https://openalex.org/C2777883359","wikidata":"https://www.wikidata.org/wiki/Q1888634","display_name":"Allodynia","level":5,"score":0.4353259205818176},{"id":"https://openalex.org/C2779761754","wikidata":"https://www.wikidata.org/wiki/Q250442","display_name":"Methylcobalamin","level":3,"score":0.42412105202674866},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4215020537376404},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3983367383480072},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35726964473724365},{"id":"https://openalex.org/C2779245659","wikidata":"https://www.wikidata.org/wiki/Q1633866","display_name":"Hyperalgesia","level":4,"score":0.3126513361930847},{"id":"https://openalex.org/C2779750884","wikidata":"https://www.wikidata.org/wiki/Q187706","display_name":"Vitamin B12","level":2,"score":0.13335007429122925},{"id":"https://openalex.org/C2776940978","wikidata":"https://www.wikidata.org/wiki/Q34956","display_name":"Vitamin","level":2,"score":0.13211989402770996},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.101896733045578},{"id":"https://openalex.org/C3019288012","wikidata":"https://www.wikidata.org/wiki/Q205130","display_name":"Vitamin b6","level":3,"score":0.0},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011733","descriptor_name":"Pyridoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015227","descriptor_name":"Lipid Peroxidation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015227","descriptor_name":"Lipid Peroxidation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D017127","descriptor_name":"Glycation End Products, Advanced","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1196/annals.1333.091","doi":"https://doi.org/10.1196/annals.1333.091","is_oa":false,"landing_page_url":"https://doi.org/10.1196/annals.1333.091","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},{"id":"pmid:16037306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16037306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1529592271","https://openalex.org/W1836107361","https://openalex.org/W1965126420","https://openalex.org/W1968290491","https://openalex.org/W1976566920","https://openalex.org/W1979869319","https://openalex.org/W1983286905","https://openalex.org/W1984540955","https://openalex.org/W1984834222","https://openalex.org/W1987604506","https://openalex.org/W1989224597","https://openalex.org/W1991359884","https://openalex.org/W1996478420","https://openalex.org/W1999809984","https://openalex.org/W2000270441","https://openalex.org/W2009340697","https://openalex.org/W2010008476","https://openalex.org/W2018933113","https://openalex.org/W2019987567","https://openalex.org/W2022939284","https://openalex.org/W2025909794","https://openalex.org/W2026473612","https://openalex.org/W2026940981","https://openalex.org/W2026983868","https://openalex.org/W2036429556","https://openalex.org/W2041653765","https://openalex.org/W2044437167","https://openalex.org/W2045232429","https://openalex.org/W2049374654","https://openalex.org/W2052939510","https://openalex.org/W2066779642","https://openalex.org/W2076715293","https://openalex.org/W2079198137","https://openalex.org/W2084449089","https://openalex.org/W2088844252","https://openalex.org/W2088931814","https://openalex.org/W2123032423","https://openalex.org/W2123438808","https://openalex.org/W2123979970","https://openalex.org/W2138969187","https://openalex.org/W2140794335","https://openalex.org/W2146655079","https://openalex.org/W2160496529","https://openalex.org/W2162431165","https://openalex.org/W2171072628","https://openalex.org/W2340223668","https://openalex.org/W2444479036","https://openalex.org/W2565865104","https://openalex.org/W3184768937"],"related_works":["https://openalex.org/W1531710708","https://openalex.org/W2104918241","https://openalex.org/W30381157","https://openalex.org/W1970842062","https://openalex.org/W2009340697","https://openalex.org/W1993428219","https://openalex.org/W3032164426","https://openalex.org/W2367894536","https://openalex.org/W2359579530","https://openalex.org/W1976976849"],"abstract_inverted_index":{"Advanced":[0],"glycation":[1],"and":[2,23,34,70,80,94,128,152,182,213],"lipoxidation":[3],"end":[4],"products":[5],"(AGEs/ALEs)":[6],"have":[7,53,64,131,136],"been":[8,133],"implicated":[9],"in":[10,47,89,107,186,211,221,237],"the":[11,14,28,31,43,116,159,177,198,226,238],"pathogenesis":[12],"of":[13,18,45,50,104,109,119,149,161,180,209,240],"major":[15],"microvascular":[16],"complications":[17],"diabetes":[19],"mellitus:":[20],"nephropathy,":[21],"neuropathy,":[22],"retinopathy.":[24],"This":[25],"article":[26],"reviews":[27],"evidence":[29],"regarding":[30],"peripheral":[32],"nerve":[33,72,78,81,212],"its":[35],"vascular":[36,214],"supply.":[37],"Most":[38],"investigations":[39],"done":[40],"to":[41,135,140,145,171,197],"assess":[42],"role":[44,234],"AGEs/ALEs":[46,236],"animal":[48],"models":[49],"diabetic":[51,222,241],"neuropathy":[52],"used":[54],"aminoguanidine":[55],"as":[56,126,142,144],"a":[57,190],"prototypic":[58],"inhibitor.":[59],"Preventive":[60],"or":[61],"intervention":[62],"experiments":[63],"shown":[65,134],"treatment":[66],"benefits":[67],"for":[68,97,231,235],"motor":[69],"sensory":[71],"conduction":[73,98],"velocity,":[74],"autonomic":[75],"nitrergic":[76],"neurotransmission,":[77],"morphometry,":[79],"blood":[82],"flow.":[83],"The":[84],"latter":[85],"depends":[86],"on":[87],"improvements":[88,210],"nitric":[90],"oxide-mediated":[91],"endothelium-dependent":[92],"vasodilation":[93],"is":[95,112,170,189],"responsible":[96],"velocity":[99],"improvements.":[100],"A":[101,167,206],"mechanistic":[102],"interpretation":[103],"aminoguanidine's":[105],"action":[106],"terms":[108],"AGE/ALE":[110,165],"inhibition":[111],"made":[113],"problematic":[114],"by":[115,175],"relative":[117],"lack":[118],"specificity.":[120],"However,":[121],"other":[122],"unrelated":[123],"compounds,":[124],"such":[125],"pyridoxamine":[127,129],"analogues,":[130],"recently":[132],"beneficial":[137],"effects":[138],"similar":[139,207],"aminoguanidine,":[141],"well":[143],"improve":[146],"pain-related":[147],"measures":[148],"thermal":[150],"hyperalgesia":[151],"tactile":[153],"allodynia.":[154],"These":[155],"data":[156,227],"also":[157],"stress":[158],"importance":[160],"redox":[162],"metal":[163],"ion-catalyzed":[164],"formation.":[166],"further":[168],"approach":[169],"decrease":[172],"substrate":[173],"availability":[174],"reducing":[176,203],"elevated":[178],"levels":[179],"hexose":[181],"triose":[183],"phosphates":[184],"found":[185],"diabetes.":[187],"Benfotiamine":[188],"transketolase":[191],"activator":[192],"that":[193],"directs":[194],"these":[195],"substrates":[196],"pentose":[199],"phosphate":[200],"pathway,":[201],"thus":[202],"tissue":[204],"AGEs.":[205],"spectrum":[208],"function":[215],"were":[216],"noted":[217],"when":[218],"using":[219],"benfotiamine":[220],"rats.":[223],"Taken":[224],"together,":[225],"provide":[228],"strong":[229],"support":[230],"an":[232],"important":[233],"etiology":[239],"neuropathy.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073715063","counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
